Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloidosis | 2 | 2022 | 878 | 0.900 |
Why?
|
Prothrombin Time | 1 | 2020 | 117 | 0.700 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2020 | 198 | 0.630 |
Why?
|
International Normalized Ratio | 1 | 2020 | 382 | 0.620 |
Why?
|
Vitamin K | 1 | 2020 | 314 | 0.590 |
Why?
|
Hematocrit | 1 | 2019 | 623 | 0.580 |
Why?
|
Electrocardiography | 6 | 2024 | 6412 | 0.530 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2665 | 0.510 |
Why?
|
Thrombosis | 2 | 2023 | 2957 | 0.510 |
Why?
|
Erythropoiesis | 1 | 2019 | 691 | 0.490 |
Why?
|
Myocardial Revascularization | 1 | 2019 | 795 | 0.480 |
Why?
|
Receptors, Thrombin | 1 | 2015 | 130 | 0.470 |
Why?
|
Blood Coagulation | 1 | 2020 | 1162 | 0.460 |
Why?
|
Drug Monitoring | 1 | 2020 | 964 | 0.460 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1323 | 0.450 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 5176 | 0.440 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.440 |
Why?
|
Echocardiography | 4 | 2022 | 5047 | 0.440 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1334 | 0.420 |
Why?
|
Myocytes, Cardiac | 5 | 2023 | 1681 | 0.420 |
Why?
|
Lactones | 1 | 2015 | 316 | 0.410 |
Why?
|
Chest Pain | 1 | 2019 | 1101 | 0.380 |
Why?
|
Anticoagulants | 4 | 2024 | 4852 | 0.370 |
Why?
|
Myocardial Infarction | 4 | 2021 | 11519 | 0.360 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1883 | 0.350 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.310 |
Why?
|
Membrane Lipids | 2 | 2019 | 252 | 0.290 |
Why?
|
Osteopontin | 2 | 2020 | 306 | 0.290 |
Why?
|
Phospholipids | 3 | 2023 | 787 | 0.280 |
Why?
|
Stroke | 3 | 2020 | 9755 | 0.260 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2194 | 0.260 |
Why?
|
Heart | 1 | 2019 | 4446 | 0.260 |
Why?
|
Femoral Fractures | 2 | 2021 | 376 | 0.250 |
Why?
|
MicroRNAs | 1 | 2021 | 3803 | 0.240 |
Why?
|
Kidney | 1 | 2019 | 7064 | 0.220 |
Why?
|
Pyridines | 1 | 2015 | 2894 | 0.210 |
Why?
|
Glutathione | 2 | 2023 | 589 | 0.200 |
Why?
|
Hypertension, Pulmonary | 2 | 2024 | 1605 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8616 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12252 | 0.190 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 2019 | 190 | 0.190 |
Why?
|
Diaphyses | 1 | 2021 | 65 | 0.180 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1901 | 0.180 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2021 | 55 | 0.180 |
Why?
|
Macrophages | 3 | 2021 | 5799 | 0.180 |
Why?
|
Cell Hypoxia | 2 | 2020 | 662 | 0.170 |
Why?
|
Heart Failure | 5 | 2023 | 11879 | 0.170 |
Why?
|
Diastole | 2 | 2019 | 785 | 0.170 |
Why?
|
Adrenal Cortex | 1 | 2020 | 134 | 0.160 |
Why?
|
Palmitic Acid | 1 | 2020 | 149 | 0.160 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 346 | 0.160 |
Why?
|
Triazines | 1 | 2021 | 311 | 0.160 |
Why?
|
Diuresis | 1 | 2019 | 107 | 0.160 |
Why?
|
Membranes | 1 | 2018 | 164 | 0.160 |
Why?
|
Hematology | 1 | 2022 | 243 | 0.150 |
Why?
|
Ventricular Dysfunction | 1 | 2019 | 144 | 0.150 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2019 | 146 | 0.150 |
Why?
|
STAT3 Transcription Factor | 2 | 2020 | 874 | 0.150 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2019 | 91 | 0.150 |
Why?
|
Sirtuin 1 | 1 | 2019 | 247 | 0.150 |
Why?
|
Cardiomyopathies | 2 | 2021 | 2056 | 0.150 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 386 | 0.140 |
Why?
|
Receptors, Glucocorticoid | 1 | 2019 | 309 | 0.140 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15454 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1104 | 0.140 |
Why?
|
Galectin 3 | 1 | 2018 | 240 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 828 | 0.130 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 480 | 0.130 |
Why?
|
DNA | 2 | 2021 | 7214 | 0.130 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5889 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2019 | 591 | 0.130 |
Why?
|
Sympathetic Nervous System | 1 | 2019 | 521 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 979 | 0.120 |
Why?
|
Administration, Oral | 2 | 2020 | 4030 | 0.120 |
Why?
|
Video Recording | 1 | 2020 | 976 | 0.120 |
Why?
|
Adenosine Triphosphatases | 1 | 2019 | 842 | 0.120 |
Why?
|
Aldosterone | 1 | 2020 | 881 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2298 | 0.120 |
Why?
|
Atrioventricular Block | 1 | 2016 | 141 | 0.120 |
Why?
|
Doxorubicin | 1 | 2021 | 2234 | 0.120 |
Why?
|
Erythropoietin | 1 | 2019 | 718 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 22371 | 0.120 |
Why?
|
Coronary Stenosis | 1 | 2020 | 802 | 0.120 |
Why?
|
Disease Progression | 2 | 2023 | 13671 | 0.110 |
Why?
|
Dystonic Disorders | 1 | 2018 | 354 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1519 | 0.110 |
Why?
|
Stroke Volume | 3 | 2024 | 5622 | 0.110 |
Why?
|
Heart Valve Prosthesis | 1 | 2022 | 1468 | 0.110 |
Why?
|
Humans | 29 | 2024 | 768166 | 0.110 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2016 | 452 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1494 | 0.110 |
Why?
|
Registries | 2 | 2020 | 8375 | 0.110 |
Why?
|
Warfarin | 1 | 2022 | 1493 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2145 | 0.100 |
Why?
|
Hemoglobins | 1 | 2019 | 1531 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.100 |
Why?
|
Japan | 3 | 2024 | 1418 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1399 | 0.100 |
Why?
|
Hip Fractures | 1 | 2021 | 997 | 0.100 |
Why?
|
Coronary Angiography | 2 | 2023 | 4541 | 0.100 |
Why?
|
Thalamus | 1 | 2018 | 1047 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2019 | 973 | 0.100 |
Why?
|
Risk Assessment | 4 | 2023 | 24315 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2605 | 0.090 |
Why?
|
Fatty Acids | 1 | 2019 | 1812 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2599 | 0.090 |
Why?
|
Heart Diseases | 1 | 2024 | 2819 | 0.090 |
Why?
|
Protein Unfolding | 2 | 2021 | 57 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 18065 | 0.090 |
Why?
|
Rheumatic Diseases | 1 | 2017 | 659 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2032 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 40218 | 0.080 |
Why?
|
Mice | 9 | 2022 | 82029 | 0.080 |
Why?
|
Mass Screening | 1 | 2024 | 5458 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3467 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5315 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2076 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15662 | 0.070 |
Why?
|
Prognosis | 4 | 2024 | 30010 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59629 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2023 | 65371 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4260 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2021 | 7876 | 0.070 |
Why?
|
Animals | 11 | 2022 | 169246 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 12800 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20227 | 0.060 |
Why?
|
Risk Factors | 6 | 2023 | 74944 | 0.060 |
Why?
|
Mutation | 2 | 2021 | 30238 | 0.060 |
Why?
|
Cell Death | 2 | 2021 | 1679 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7608 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9538 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8080 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3433 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2021 | 19015 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2021 | 14488 | 0.060 |
Why?
|
Male | 13 | 2024 | 364719 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6568 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14729 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13014 | 0.050 |
Why?
|
Aged | 8 | 2024 | 171504 | 0.050 |
Why?
|
Reperfusion | 1 | 2023 | 266 | 0.050 |
Why?
|
Incidence | 4 | 2024 | 21538 | 0.050 |
Why?
|
Phosphatidylcholines | 1 | 2023 | 406 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8744 | 0.050 |
Why?
|
gamma-Glutamylcyclotransferase | 1 | 2021 | 11 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2022 | 137 | 0.050 |
Why?
|
Anthracyclines | 1 | 2024 | 286 | 0.050 |
Why?
|
Blood Cells | 1 | 2023 | 309 | 0.050 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2024 | 418 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22379 | 0.050 |
Why?
|
Female | 11 | 2024 | 397192 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11928 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13676 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3941 | 0.040 |
Why?
|
Rats, Inbred Dahl | 1 | 2020 | 34 | 0.040 |
Why?
|
Sterol Esterase | 1 | 2020 | 39 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 681 | 0.040 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2020 | 63 | 0.040 |
Why?
|
RING Finger Domains | 1 | 2019 | 7 | 0.040 |
Why?
|
Zona Glomerulosa | 1 | 2020 | 87 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7951 | 0.040 |
Why?
|
Catecholamines | 1 | 2020 | 389 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54926 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2018 | 101 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2022 | 881 | 0.040 |
Why?
|
Phosphorylation | 2 | 2020 | 8317 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 223492 | 0.040 |
Why?
|
Asia | 1 | 2019 | 629 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23645 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2018 | 239 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18349 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1751 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1946 | 0.030 |
Why?
|
Septal Occluder Device | 1 | 2016 | 126 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2131 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2018 | 594 | 0.030 |
Why?
|
Mast Cells | 1 | 2022 | 1406 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1900 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2023 | 1567 | 0.030 |
Why?
|
Rats | 2 | 2021 | 23760 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2020 | 2678 | 0.030 |
Why?
|
Histones | 1 | 2024 | 2601 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2020 | 1133 | 0.030 |
Why?
|
Phenotype | 2 | 2023 | 16726 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4539 | 0.030 |
Why?
|
Phagocytosis | 1 | 2018 | 1530 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1750 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1970 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1793 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4283 | 0.020 |
Why?
|
Adult | 6 | 2024 | 223646 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6340 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2937 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1281 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2414 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4120 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2464 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2914 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1904 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3139 | 0.020 |
Why?
|
RNA Interference | 1 | 2018 | 2832 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5902 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6283 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39348 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12077 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 81762 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15597 | 0.020 |
Why?
|
Myocardium | 1 | 2018 | 4788 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12840 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12795 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 16045 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8543 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 60066 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14783 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41754 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 89169 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15948 | 0.010 |
Why?
|
Child | 1 | 2022 | 80917 | 0.010 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_